3% Sodium Chloride

DRUG5 trials

Sponsors

Montefiore Medical Center, Coordinación de Investigación en Salud, Mexico, Stanford University, University of Missouri-Columbia, Can Tho University of Medicine and Pharmacy

Conditions

Acute BronchiolitisBronchiolitisCerebral EdemaDysphagiaSaline Solution, HypertonicWheezing

Early Phase 1

Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation

WithdrawnNCT03330704

Stanford UniversityCerebral Edema, Saline Solution, Hypertonic

Start: 2017-11-28End: 2020-01-01Updated: 2020-03-19

Phase 1

Effects of 3% Sodium Chloride on Post-operative Dysphagia Following Anterior Cervical Spine Surgery

WithdrawnNCT03677310

University of Missouri-ColumbiaDysphagia

Start: 2018-04-30End: 2019-11-30Updated: 2019-04-03

Phase 2

Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis

CompletedNCT06558461

Can Tho University of Medicine and PharmacyAcute Bronchiolitis

Start: 2022-06-01End: 2024-05-28Updated: 2024-08-16

Phase 4

Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants

CompletedNCT02233985

Coordinación de Investigación en Salud, MexicoBronchiolitis, Wheezing

Start: 2013-08-31End: 2017-03-31Updated: 2017-06-21

Unknown Phase

A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis

CompletedNCT01488448

Montefiore Medical CenterBronchiolitis

Start: 2011-11-30End: 2015-08-31Updated: 2017-02-02